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Abstract
Background: Tuberculosis (TB) notification in India by the Revised National TB Control Programme (RNTCP) provides
information on TB patients registered for treatment from the programme. There is limited information about the proportion
of patients treated for TB outside RNTCP and where these patients access their treatment.
Objectives: To estimate the proportion of patients accessing TB treatment outside the RNTCP and to identify their basic
demographic characteristics.
Methods: A cross sectional community-based survey in 30 districts. Patients were identified through a door-to-door survey
and interviewed using a semi-structured questionnaire.
Results: Of the estimated 75,000 households enumerated, 73,249 households (97.6%) were visited. Of the 371,174
household members, 761 TB patients were identified (,205 cases per 100,000 populations). Data were collected from 609
(80%) TB patients of which 331 [54% (95% CI: 42–66%)] were determined to be taking treatment ‘under DOTS/RNTCP’. The
remaining 278 [46% (95% CI: 34–57%)] were on treatment from ‘outside DOTS/RNTCP’ sources and hence were unlikely to
be part of the TB notification system. Patients who were accessing treatment from ‘outside DOTS/RNTCP’ were more likely
to be patients from rural areas [adjusted Odds Ratio (aOR) 2.5, 95% CI (1.2–5.3)] and whose TB was diagnosed in a non-
government health facility (aOR 14.0, 95% CI 7.9–24.9).
Conclusions: This community-based survey found that nearly half of self-reported TB patients were missed by TB
notification system in these districts. The study highlights the need for 1) Reviewing and revising the scope of the TB
notification system, 2) Strengthening and monitoring health care delivery systems with periodic assessment of the reach
and utilisation of the RNTCP services especially among rural communities, 3) Advocacy, communication and social
mobilisation activities focused at rural communities with low household incomes and 4) Inclusive involvement of all health-
care providers, especially providers of poor rural communities.
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Introduction
The global targets for reducing the Tuberculosis (TB) incidence,
prevalence and mortality for 2015 have been outlined by the Stop
TB Partnership. These targets are set within the overall context of
the Millennium Development Goals (MDGs) and are that the
global TB incidence rate should be falling by 2015 and that TB
prevalence and death rates should be halved by 2015 compared
with their levels in 1990 [1,2].
Due to numerous challenges in measuring incidence, prevalence
and mortality, the World Health Organization (WHO) Task Force
on TB Impact Measurement has developed a standard framework
which outlines the related analyses and tools for this purpose. The
major recommendation of this Task Force is that all countries
should strengthen their routine surveillance systems (TB-specific
recording and reporting systems and/or general health informa-
tion systems) and ensure that all TB cases are captured by this
system [3].
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24160India is one of the high TB burden countries accounting for one
fifth of the global incidence of TB and tops the list of 22 high TB
burden countries [4]. The only available source of TB patient
related information is from the Government of India’s Revised
National TB Control Programme (RNTCP) which uses standard-
ized recording and reporting systems spread throughout the
country for systematically collecting, analyzing and disseminating
data. This recording and reporting system is in alignment with the
WHO recommended standard recording and reporting system for
National TB Programmes and captures information on TB
patients initiated on treatment using the drugs and regimens
prescribed by RNTCP [5,6].
TB care in India is provided by both public and non-public
sector health facilities [7]. Patients from the public sector are
usually managed within the programmatic setting as specified by
RNTCP guidelines and are captured by the RNTCP based TB
notification system in India. While RNTCP has made concerted
efforts to involve non-public health providers in promoting TB
care, it is believed that many patients continue to seek treatment
from providers outside programme settings [8,9] and therefore go
unreported under the existing TB notification systems [6].
However, evidence from published literature neither provides a
reliable estimate nor a proportion for such TB patients who seek
care from the non-public health providers.
A community based study was undertaken to estimate the
number of self reported TB patients who are currently on TB
treatment, the proportion that are accessing TB treatment outside
the programmatic setting and their basic socio demographic
characteristics.
Methods
Study Setting
The Global Fund Round 9 India TB project (IDA-910-G17-T)
seeks to increase civil society’s support to the national TB
programme in India and to engage communities and community
based care providers in 374 out of 650 districts across 21 of the 35
states and union territories in the country. These 374 districts were
selected based on low TB case detection or because of limited
access of populations to health services, In 2011, a baseline survey
of knowledge, attitudes and practices of the community to TB was
conducted in a representative sample of 30 of the 374 districts to
provide pre-project implementation information to inform impact
assessment; full results of this baseline survey are under analysis
and will be reported separately. A limited dataset collected during
this survey from patients undergoing TB treatment was used for
this analysis.
Study design, sample size, sampling and study
population
We used a cross-sectional study design. In the absence of
reliable estimates, we assumed that 30% of the TB cases in the
community are being treated outside RNTCP. A sample size of
710 TB patients was needed to estimate the proportion treated
outside RNTCP with a precision of 65%, considering a 10% non-
response rate and with a design effect of 2 to account for cluster
sampling. The estimated population prevalence of TB in India is
249 TB cases per 100,000 population [4] and we assumed that
90% of the cases will be on TB treatment. A population of at least
300,000 was required to identify the required number of TB
patients for the study.
Thirty districts out of the 374 global fund project districts
(Figure 1) were selected by a stratified cluster sampling technique.
Districts were initially stratified into the 4 RNTCP zones (north,
south, east and west) of the country. The number of districts in
each zone was selected in proportion to the distribution of the 374
districts in the respective zones of the country and the required
number of districts in each zone was selected by population
proportionate to size sampling. (Table 1).
From each of these districts, the population was divided into
urban and rural primary sampling units of approximately 250
households (the approximate population in each household is 4
and the approximate size of the primary sampling unit is 1000
population), based on the data available from the country’s 2001
census. Ten primary sampling units were selected randomly (using
the random numbers generated at www.random.org) in each
district from the urban and rural primary sampling units in
proportion to the districts’ estimated urban and rural population.
Study investigators, data collection, study instrument
and study variables
The study was implemented by The Union, South-East Asia
Regional Office with assistance from field investigators of the
social research organization GfK MODE. The trained field
investigators visited the preselected primary sampling units during
the months of January to March, 2011 and conducted a household
line listing. During this line listing process, TB patients were
identified by interviewing heads of the households or other
available household members to know whether any current
household member was known to be suffering from TB (or an
equivalent local term referring to TB). A current household
member was defined as a person who is alive and has stayed in the
household for at least 6 months prior to this survey.
A semi-structured questionnaire was used to collect information
from these identified TB patients (their guardian was selected in
case the TB patient was aged less than 18 years). This semi-
structured questionnaire included data on age, sex, total current
monthly household income from all sources (in Indian rupees),
literacy status (an illiterate was considered as a person who cannot
read and write in any language), source of TB diagnosis (whether it
is government or non-government health facility), site of disease
(pulmonary or extra-pulmonary), whether treated for TB in the
past and their source of TB treatment. Given the large,
decentralised nature of data collection, based on the experiences
during pre-testing of the study methodology, the questionnaire was
simplified in a manner in which the patients could understand and
respond reliably.
We defined operationally the source of TB treatment to be from
‘DOTS/RNTCP’ if patients stated that the drugs they consumed
were provided free of cost (as treatment under RNTCP is provided
free of cost), by the government health facilities or non-
government health facilities, taken thrice weekly from patient
wise boxes, and/or the drugs were consumed in the presence of a
health worker. Additional information was sought to determine if
the patient had an identity card provided by RNTCP. In the
absence of this information, or if the drugs were being consumed
contrary to this procedure, we defined the patient as taking
treatment from ‘outside DOTS/RNTCP’ sources.
Data entry and analysis
Data collected from the field by the investigators were entered
into a pre-structured format in Fox Pro (Version 2.6), cross verified
for consistency and were analyzed using Epi-data (version 2.2.1)
and Stata (Version 10). Variables were summarized by proportions
and 95% confidence intervals (95% CI) were calculated using
cluster analysis to account for cluster sampling methodology.
Differences between sub-groups were measured by odds ratios
(OR) with 95% confidence intervals. All patient variables included
Source of TB Treatment, India
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other. Hence, we have done unconditional logistic regression for
calculating the adjusted odds ratio (aOR) for identifying the
statistically significant patient characteristics that were associated
with accessing treatment from ‘outside DOTS/RNTCP’. A p-
value less than 0.05 were taken to be statistically significant.
Ethical Considerations
The study protocol was approved by the Ethics Advisory Group
of The Union. In addition, as this is an approved activity under the
Global Fund Round 9 project, Central TB Division, Ministry of
Health and Family Welfare, Government of India provided
consent to this study. Prior to conducting the survey, permission
Figure 1. State and district map of India showing the Global Fund Round 9 India TB project districts, and the 30 districts that were
selected for the survey.
doi:10.1371/journal.pone.0024160.g001
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primary sampling units in each district. Written consent was also
sought from the heads of households and individual TB patients.
Results
Of the estimated 75,000 households, 73,249 households (97.6%)
were visited during the survey. There was a total of 371,174
household members of whom 761 reported that they were on TB
treatment [approximates to 205 TB patients per 100,000
populations; (95% CI: 146–260 TB patients per 100,000
population)] during the household listing process. However, 152
(20%) of these patients could not be interviewed either because,
written consent was not given or the head of the household and/or
the patients could not be contacted on two attempts on successive
days during the survey. Data were collected from 609 (80%) TB
patients. There were no statistically significant Zonal and urban-
rural differences between the proportion of patients interviewed
and those not interviewed.
The characteristics of TB patients interviewed
The characteristics of the 609 interviewed TB patients are
shown in Table 2. More than half (64%) of the patients were
males. Nearly three fourths (73%) of the patients were in the age
group 25–54 years. A large proportion (43%) was illiterate
(inability to read and write in any language). Almost eighty
percent of patients were from households with a current total
household income less than Indian Rupees (INR) 4000 per month
from all sources [1 United States Dollar (USD)=45 INR]. Three
fourths (77%) were new TB cases (first episode of tuberculosis).
Overall, of the 609 TB patients, 331 [54% (95% CI 42–66%)]
were determined to be taking treatment ‘under DOTS/RNTCP’
either from government or non-government health centers and the
remaining 278 [46% (95% CI 34–57%)] were on treatment from
‘outside DOTS/RNTCP’ sources.
Characteristics of TB patients in relation to source of TB
treatment
The bivariate analysis showing characteristics of TB patients in
relation to their source of TB treatment are shown in Table 3.
While a large proportion of TB patients accessing treatment
‘outside DOTS/RNTCP’ were illiterate (48%) and from rural
areas (86%), the characteristics that were statistically significant
when compared to those accessing treatment ‘under DOTS/
RNTCP’ were current household income (#INR 4000), setting
(rural) and the source of diagnosis (non-government health
facility). Some crossover between diagnosis and treatment was
observed; 14% of those diagnosed in the private sector were
treated ‘under DOTS/RNTCP’, while 30% diagnosed at the
government health facility sought treatment ‘outside DOTS/
RNTCP’. In addition, not all patients treated from the
government health facilities were treated ‘under DOTS/RNTCP’
and ,6% were treated ‘outside DOTS/RNTCP’—an unusual
observation as nationwide public health facilities do not indepen-
dently procure first-line anti-TB drugs.
Based on multivariate analysis (Table 4) patients who were
accessing treatment from ‘outside DOTS/RNTCP’ were more
likely to be patients from rural areas [adjusted odds ratio (aOR)
2.5, 95% CI 1.2–5.3]. The characteristic most strongly associated
with treatment ‘outside DOTS/RNTCP’ was TB diagnosed in a
non-government health facility (aOR14.0, 95% CI 7.9–24.9).
Discussion
This is one of the few community-based surveys in India
providing information on the overall prevalence of patients on TB
treatment (by self-report) and their source of diagnosis and
treatment. This population-based survey of more than half the
districts in the country found 205 self-reported TB patients per
100,000 populations. This finding highlights that TB remains a
disease of public health importance in India, and that the disease
burden remains high after more than a decade of intensive TB
control efforts led by RNTCP. In addition, they also help to
identify the profile of patients who are not accessing TB treatment
services under RNTCP.
This finding is consistent with that from other surveys of TB
prevalence and self-reported TB prevalence from India, though
nationally-represented prevalence data are not available [4]. Data
from the 3
rd National Health and Family Survey (NHFS) had
shown that prevalence of medically treated TB was 418 per
100,000 usual household residents, with higher prevalence in men.
NHFS however, did not refer only to patients being currently
treated for tuberculosis as has been done in our survey [10].
What are the implications of this study for RNTCP? First, the
current TB notification system requires expansion to reach
patients diagnosed and treated outside direct RNTCP services.
RNTCP is moving towards ‘universal access’ to TB diagnosis and
treatment under RNTCP and aims to detect and treat at least 90%
of the estimated TB cases in the community [11]. In the absence of
nationally representative surveys, the TB disease burden has to be
estimated indirectly (using the ‘onion model’) from the data on TB
notification as outlined by the WHO Task Force on TB impact
measurement [3]. As mentioned earlier, the TB notification system
in India is based on TB cases accessing treatment under the
RNTCP and it is known that a large proportion of TB patients
access treatment outside the RNTCP. In this scenario, one of the
key pieces of information required for the indirect estimation is an
answer to the question ‘‘What fraction of cases is missed in TB
notification data’’? This study, by providing information that 46%
(95% CI 34–57%) of TB patients may not be notified under the
programme, provides data for estimating the burden of TB by this
indirect method as outlined by the WHO Task Force on TB
Impact Measurement [3]. In order to make the TB notification
system in India complete, mechanisms have to be initiated in India
to capture these TB cases that are accessing treatment ‘outside
RNTCP’ by expanding the scope of the current TB notification
system.
Second, TB has been and remains a disease that largely afflicts
the impoverished, and that needs to be incorporated into TB
programme planning. Universally, the poor and socially vulner-
able groups are at higher risk for TB disease and death [12].
Although the national programme in India is designed to benefit
Table 1. Total number of districts selected zone wise from
the Global Fund Round 9 Project districts for the cross-
sectional community based survey, India, 2011.
Zones
Total number of Districts
under the Project
No. of districts to be
selected
North Zone 89 7
South Zone 60 6
East Zone 120 9
West Zone 105 8
Grand Total 374 30
doi:10.1371/journal.pone.0024160.t001
Source of TB Treatment, India
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study show that large proportions of patients who are accessing
treatment ‘outside DOTS/RNTCP’ are illiterate, live in very low
income households, in rural areas and have to pay for their
treatment. The current levels of income in households of patients
who are on treatment are likely to be lower than their past and
regular incomes, because of inability to work, or return to full
work. This has important implications for TB control and the
alleviation (or exacerbation) of poverty in the country. Reasons for
patients seeking care from outside the national programme are
many, and include poor knowledge about the disease and the
services available through the national programme [13,14]; they
Table 2. Characteristics of self reported TB patients in a community based survey in India, 2011 (n=609).
Characteristics N % (95% CI)
Sex
Female 220 36.1 (29.9–42.3)
Male 389 63.9 (57.7–70.1)
Age Group (in years)
,15 13 2.1 (0.9–3.3)
$15 to ,25 99 16.3 (12.7–19.7)
$25 to ,35 101 16.6 (13.8–19.2)
$35 to ,45 134 22.0 (17.9–26.9)
$45 to ,55 107 17.6 (13.6–21.5)
$ to ,65 95 15.6 (12.3–18.8)
$65 60 9.9 (6.9–12.7)
Literacy status
illiterate 264 43.3 (35.0–51.6)
literate 345 56.7 (48.4–65.0)
Current monthly household income from all sources (in INR)
*
,2000 212 34.8 (25.9–43.6)
2000–4000 270 44.3 (38.1–50.5)
4001–8000 64 10.5 (6.1–14.8)
8001–10,000 22 3.6 (1.3–5.9)
.10,000 11 1.8 (0.1–3.4)
Don’t Know 30 4.9 (1.1–8.7)
Residence
Rural 468 76.8 (64.1–89.5)
Urban 128 21.0 (8.6–33.4)
Unknown 13 2.1 (0.3–3.9)
Type of TB
New 470 77.2 (69.6–84.7)
Previously treated 139 22.8 (15.3–30.4)
Source of TB diagnosis
Government health facility 366 60.1 (46.3–73.8)
Non-Government health facility 236 38.8 (25.3–52.1)
others/unknown 7 1.1 (0.3–1.9)
TB Site
Pulmonary 573 94.1 (91.5–96.6)
Extra-pulmonary 28 4.6 (2.8–6.3)
Unknown 8 1.3 (0.0–2.6)
Source of TB treatment
Government health centres, free of cost under DOTS/RNTCP 310 50.9 (38.4–63.4)
Non-government health centres, free of cost under DOTS/RNTCP 21 3.4 (1.6–5.2)
Government health centres, with payment for medicines (outside DOTS/RNTCP) 36 5.9 (3.1–8.6)
Non government health centres, with payment for medicines (outside DOTS/RNTCP) 218 35.8 (24.5–47.0)
Other sources-non allopathic medicines(outside DOTS/RNTCP) 24 3.9 (1.8–6.0)
*1 United States Dollar=,45 Indian National Rupees.
doi:10.1371/journal.pone.0024160.t002
Source of TB Treatment, India
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confidentiality and a desire for personalized care [15].
Third, crossover of patients after diagnosis at the stage of
seeking treatment or even during treatment, from one type of
healthcare provider to another was observed in our study. A study
on care seeking behavior in South India showed that the RNTCP
has had an impact in the community with regard to the availability
and accessibility of TB services in government health facilities.
However relatively large numbers of the chest symptomatic
patients had subsequently shifted to the non-Government health
facilities prompting the authors to recommend urgent measures to
make government facilities more patient friendly [16]. Another
study in Delhi during the early phase of RNTCP implementation
had shown that health workers screened TB patients to assess
whether the patients would adhere to treatment. In this process,
patients mainly those who were in absolute poverty, socially
marginalized, itinerant labourers, poorly integrated in the city,
were not put on treatment regimens as recommended under
RNTCP as the health workers felt that these patients would not
adhere to treatment [17]. The large advocacy, communication
and social mobilisation project coordinated by civil society through
the Global Fund Round 9 India TB grant has the potential to
address these barriers and complement the national programme’s
efforts in reaching poor and vulnerable communities.
Fourth, TB patients who were diagnosed in the non-
government health facilities are more likely to be treated outside
the programme setting, and this may not be in accordance with
the patient management outlined in International Standards of TB
care (ISTC) [8,18]. The number of such non-governmental health
facilities in India run into hundreds of thousands. It is estimated
that over 80% of all health care in the country is accessed from the
non government sector [19], with less than 45% of the inpatient
care sought from the government (public) health facilities [20].
Data from the 60
th Round of the National Sample Survey
Organisation of India, corresponding to the year 2004, had shown
that younger age group, women, people with higher level of
Table 3. Characteristics of self Reported TB patients (n=609) in relation to their source of TB treatment in a Community based
Survey in India, 2011 (Bi-variate analysis).
Characteristics
Outside DOTS/RNTCP
N( % ) Under DOTS/RNTCP
Odds ratio
(95% CI)
N( % )
Sex
Female 108 (39) 112 (34) 1.24 (0.9–1.7)
Male 170 (61) 219 (66) Referent
Age Group (in years)
,25 54 (19) 58 (18) 1.16 (0.5–1.3)
25–54 years 152 (55) 190 (57) Referent
$55 72 (26) 83 (25) 1.08 (0. 7–1.7)
Literacy status
Illiterate 133 (48) 131 (40) 1.40 (0.8 –2.3)
Literate 145 (52) 200 (60) Referent
Current monthly household income (in INR)
*
#4000 237 (85) 245 (74) 1.96 (1.1–3.4)
**
.4000 32 (12) 65 (20) Referent
Unknown 9 (3) 21 (6)
Setting
Rural 239 (86) 229 (69) 2.66 (1.1–6.3)
**
Urban 36 (13) 92 (28) Referent
Unknown 3 (1) 10 (3)
Type of TB
New 219 (79) 251 (76) 1.18 (0.5–2.5)
previously treated 59 (21) 80 (24) Referent
Body site affected by TB
Pulmonary 263 (95) 310 (94) 1.79 (0.6–5.2)
Extra-pulmonary 9 (3) 19 (6) Referent
Unknown 6 (2) 2 (1)
Diagnosis Source
non-Government health facility 191 (69) 45 (14) 14.47 (8.6–24.4)
**
Government health facility 83 (30) 283 (85) Referent
others (including unknown) 4 (1) 3 (1)
*1 United States Dollar=,45 Indian Rupees (INR).
**Statistically significant.
doi:10.1371/journal.pone.0024160.t003
Source of TB Treatment, India
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at non-government sector facilities [21]. Tremendous efforts have
been made by the TB programme to reach out to the vast non-
government sector health facilities through various innovative
mechanisms using public private mix approaches and by advocacy
through various medical professional associations. These efforts,
however, appear to be inadequate given the health care system in
the country [22,23]. The responsibility for participating in
organized TB control efforts also rests with all health care
providers who manage TB patients as per the ISTC, and this
message needs to be communicated to all the health care providers
in the country as many may not be aware [24,25].
Limitations
While we believe that the findings are valid, there are some
limitations to the study. First, these data are not nationally
representative but representative of the 374 Global Fund Round 9
ACSM intervention districts. As mentioned previously under study
setting, these districts were selected for the project interventions by
RNTCP based on their relatively poor programme performance.
The situation may or may not be the same in other 276 districts of
the country. Second, the study identified TB patients based on a
door to door household survey and by enquiring about TB disease
status (Self reported). This methodology has its limitations in that
only diagnosed TB patients who voluntarily disclose their disease
and treatment status will be captured. If the patients are not
diagnosed in the community, or if they do not disclose their disease
status voluntarily due to reasons such as stigma, then this survey
would have missed such cases. Third, we were not able to cross
check the accuracy of the TB disease diagnosis and the
appropriateness of treatment as the clinical records that were
available with many patients (,40%) were incomplete. If for any
reason, the diagnosis of TB disease was inaccurate or if the therapy
was inappropriate, then our study findings may not have provided
the correct picture of the patients on TB treatment. Fourth,w e
were not able to interview nearly 20% of the TB patients identified
in this survey due to certain operational and ethical reasons as
mentioned above. The only two variables by which we could assess
whether the patients interviewed were similar to the patients not
interviewed were the zone and the urban/rural status of the
patients. If there were differences in other variables between those
included and not included, then this has to potential to change the
study results. These are usual limitations of any community based
surveys.
Conclusion and recommendations
India has declared the intent to achieve by 2017 ‘universal
access’ to TB diagnosis and treatment for all TB cases in the
Table 4. Multivariate analysis for characteristics associated with patients accessing TB treatment ‘outside DOTS/RNTCP’ in a
community based survey, India, 2011 (N=555).
Characteristics Adjusted odds ratio (95% CI) P- Value
Sex
Male referent
Female 1.24 (0.8–1.9) 0.299
Age Group
25–54 years referent
,25 1.08 (0.6–2.1) 0.787
.=55 0.92 (0.5–1.7) 0.782
Literacy status
literate referent
Illiterate 1.26 (0.7–2.2) 0.380
Current monthly household income (in INR)
*
.4000 referent
#4000 1.81 (0.9–3.7) 0.100
Setting
Urban referent
Rural 2.48 (1.2–5.3) 0.021
**
Type of TB
previously treated referent
New 0.73 (0.4–1.3) 0.292
Body site affected by TB
Extra-pulmonary referent
Pulmonary 2.94 (0.9–9.9) 0.079
Diagnosis Source
Government health facility referent
Non-Government health facility 14.03 (7.9–24.9) ,0.001
**
*1 United States Dollar=,45 Indian Rupees (INR).
**Statistically significant.
doi:10.1371/journal.pone.0024160.t004
Source of TB Treatment, India
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and treated in the private sector [11] Nearly half of all patients
treated for TB in these 30 districts are treated ‘outside DOTS/
RNTCP’ sources and many not be notified. The study highlights
the need for future research, programme policies and activities on
1) Reviewing and revising the scope of the TB notification system,
2) Further strengthening and monitoring of health care delivery
systems especially to the rural communities with periodic
assessment of reach and utilisation of the TB services 3). Advocacy,
communication and social mobilisation activities focused at rural
communities with low household incomes and 4) Inclusive
involvement of all care providers, especially non government
providers of poor rural communities.
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